“PO12 | Characterisation and Real Word Clinical Data of HEM006, a Newly Formulated Intranasal Spray Desmopressin (DDAVP) to Address a Global Treatment Gap: G. De Giorgi1, A. Gringeri2, R. Franceschini1, A. Koganti3 | 1Hemorare Srl, Italy; 2Fondazione Charta, Milan, Italy; 3Quenya LLC, USA”. Bleeding, Thrombosis and Vascular Biology 4, no. s1 (October 22, 2025). Accessed April 25, 2026. https://www.btvb.org/btvb/article/view/274.